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Background: Human Immunodeﬁciency Virus largely has con-
tributed to infant and child mortality in Uganda today and Africa
at large. Women have the potential to transmit HIV to their
children during pregnancy, labor and post-natally; about 30-40%
of these children acquire the infection in the postnatal period
(http;//womenchildrenhiv.org). To minimize postnatal mother to
child transmission (MTCT) of HIV, Various feeding options have
been tried but their success has been challenged because little is
known about the mothers’ beliefs and knowledge about such mea-
sures, which thus calls for further investigations into this practice.
Methods & Materials: We did a descriptive cross sectional sur-
vey in a post conﬂict district (more than 2 decades of unrest) to
assess the mothers’ knowledge and practice of modiﬁed infant
feeding (MIF) in prevention of postnatal MTCT of HIV. We inter-
viewedHIVpositivemothers bringing their children to YoungChild
Clinic (YCC) and Early Infant Diagnosis clinic (EID) at Gulu Regional
Referral Hospital (GRRH) from December 2012 to February 2013.
Results: Out of the 400 HIV positive mothers that were inter-
viewed, 260 (65.1%) were aware of MIF but only 129 (49.6%) put
the knowledge into practice
About 73.6%of themotherswere aware of initiating supplemen-
tary feeds at 6 months, 91.71% knew they were meant to wean off
their babies at the age of one year; 67.4% were informed about
replacement feeding. About Practice, 69.3% were breast feeding
their infants at the right frequency, 59% introduced supplementary
feeds at the right time and 93.5% weaned at the right time.
Conclusion: A good proportion of the HIV positive mothers
(65.1%) were knowledgeable about MIF but very few (49.6%)) were
applying the knowledge which therefore means that there is still
a high risk of MTCT of HIV. Therefore this means that apart from
knowledge, other factors such as mothers’ attitude towards MIF,




Final Abstract Number: 42.129
Session: Poster Session II
Date: Friday, March 4, 2016
Time: 12:45-14:15
Room: Hall 3 (Posters & Exhibition)
CD4 pattern in HIV positive patients on HAART
exposed to moringa oleifera leaf powder in
south east Nigeria
E.N. Ogbuagu1,∗, S. Ufearo2, C.N. Ogbuagu3, R.
Okonkwo1
1 Nnamdi Azikiwe University Teaching Hospital,
Nnewi, Nigeria
2 Nnamdi Azikiwe University, Nnewi, Nigeria
3 Nnamdi Azikiwe University Teaching Hospital
(NAUTH) Nnewi, Nnewi, Anambra State, Nigeria
Background: HIV infects vital cells in the human immune sys-
tem such as helper T cells (speciﬁcally CD4 T cells), macrophages,
and dendritic cells (Cunningham et al,2010). HIV infection leads
to low levels of CD4 T cells through a number of mechanisms,
including apoptosis of uninfected bystander cells (Garg et al,2012)
direct viral killing of infected cells, and killing of infected CD4+ T
cells by CD8 cytotoxic lymphocytes that recognize infected cells
(Kumar,Vinay,2012). Moringa trees are edible and have long been
consumed by humans and has also been advocated as an outstand-
ing indigenous source of highly digestible protein. Moringa has
beenused tocombatmalnutrition.Moringa’s antioxidantandnutri-
tional beneﬁts cannot directly compete with the superior results of
modern antiretroviral, even though it shows promise in providing
reduced mortality rates and improved health for HIV-positive and
AIDS patients.
Methods & Materials: A total of 40 (15 males and 25 females)
consenting adult HIV Patients who had been on highly active anti
retroviral therapy (HAART) for more than a year were enrolled into
the study. The age range was from 18 to 65 years with a mean of
42.5 years. The design was longitudinal randomised convenience
sample technique with pre and post treatment check up. Ethical
approval was obtained from Nnamdi Azikiwe University Teaching
Hospital. Subjects were exposed to 20g daily Moringa oleifera leaf
powder (MOLP) mixed with any local meal prepared with palm oil
daily for two months. The pre and post CD4 counts were analysed.
Results: The result showed a marked increase in the male post-
test CD4 value of 496.1± 61.52 cells/mm3when comparedwith the
pre-test CD4 value of 362.7± 49.68 cells/mm3 [P<0.05 (0.0003)].
Also there was a signiﬁcant increase in the female post-test CD4
value of 547.6 ± 57.9 cells/mm3 compared with pre-test CD4 value
of 459.7± 40.65 cells/mm3 [P<0.05 (0.0031)]. Comparatively, there
was a gender difference with the males (496.1 ±40.65) gaining
more than the females (547.6 ±57.9) irrespective of the number
that was enrolled (P<0.05).
Conclusion:Moringa oleifera has the potential of improving the
CD4 count of HIV positive patients on HAART translating to better
treatment outcome.
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